State Of Wyoming Kezar Life Sciences, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.58 - $17.13 $10,076 - $37,686	-2,200 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$12.3 - $18.33 $836 - $1,246	68 Added 3.19%	2,200 $36,000
Q4 2021 Feb 11, 2022	BUY	$7.44 - $16.72 $877 - $1,972	118 Added 5.86%	2,132 $36,000
Q3 2021 Feb 11, 2022	BUY	$4.85 - $9.73 $1,222 - $2,451	252 Added 14.3%	2,014 $17,000
Q2 2021 Feb 11, 2022	BUY	$4.93 - $6.46 $8,686 - $11,382	1,762 New	1,762 $10,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $449M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.